http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-116892-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14 |
| filingDate | 2015-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-116892-C2 |
| titleOfInvention | PHARMACEUTICAL COMPOSITION |
| abstract | The invention relates to a pharmaceutical composition based on a stable solution of two active substances, where as the first active substance contains low molecular weight hyaluronic acid and / or its pharmaceutically acceptable salt, the molecular weight of such acid or salt may be from 100 kDa to 400 kDa, as the second active substance - decamethoxin or its water-soluble salt, a stabilizer that is a pharmaceutically acceptable salt capable of dissolving in water and dissociating in aqueous solutions to metal cations and anions of acid residues, or a mixture of such salts, the stabilizer having the ability to form concurrently with hyaluronic acid and / or its pharmaceutically acceptable salt and with decamethoxin or its water-soluble salt-soluble compound, and containing at least one pharmaceutically acceptable additive. |
| priorityDate | 2015-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.